About 34 percent of uninsured U.S. adults did not take their medication as prescribed in 2017 in order to reduce their prescription drug costs, according to a Centers for Disease Control and Prevention report released today. According to the report, among U.S. adults aged 18-64 who were prescribed medication in the past 12 months, the percentage who did not take their medication as prescribed, asked their doctor for a lower-cost medication, or used alternative therapies to reduce prescription drug costs decreased from 2013 through 2015, and then remained relatively constant from 2015 through 2017. In 2017, strategies for reducing prescription drug costs were most commonly practiced among those who were uninsured, as 39.5 percent asked their doctor for a lower-cost medication and 13.9 percent used alternative therapies. Women were more likely than men to use these strategies, according to the report. 
 
AHA has recommended a number of policy solutions to restrain drug prices, from addressing anticompetitive actions by brand-name drug manufacturers to speeding up generic drug approvals and passing the CREATES Act.
 

Headline
The AHA commented today on the Centers for Medicare & Medicaid Services’ proposed rule on the Global Benchmark for Efficient Drug Pricing Model, or…
Headline
The Administration for Strategic Preparedness and Response Feb. 18 announced an investment that will focus on resolving a frequent shortage of oseltamivir,…
Headline
The House Energy and Commerce Subcommittee on Health Feb. 11 hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the…
Headline
The White House yesterday launched TrumpRx, the direct-to-consumer platform that will serve as a hub to direct cash-paying consumers to drug manufacturers…
Headline
The Department of Labor has issued a proposed rule to improve transparency of fees collected by pharmacy benefit managers. The rule requires PBMs to disclose…
Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…